Neuron23 Stock

Neuron23 is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Neuron23 stock. Depending on Neuron23’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Neuron23 stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.

Collective Liquidity can provide liquidity to shareholders of Neuron23 stock in two ways. First, Neuron23 employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Neuron23 stock. Note that all transactions in Neuron23 shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.

Neuron23 stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Neuron23 stock. Typically, shares of private companies like Neuron23 are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.

On Mar 2022, Neuron23 is reported to have closed an equity financing in which the investors valued the company at $507M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Neuron23 shares outstanding assuming the conversion of all stock options, warrants, etc.

Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Neuron23 is not currently publicly traded, it does not have a ticker symbol.

Neuron23 has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Neuron23 is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Neuron23 shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.